DeepDerm — The smarter way to screen for skin cancer.

The problem

Around 80% of skin biopsies come back clear. That is more than 600,000 needless procedures in Australia each year, wasting $400 million AUD. DeepDerm is built to catch that at the point of care.

The solution

DeepDerm brings together precision imaging, explainable AI, and a skin diary, so a single consultation extends naturally into the care that follows.

In the clinic

Between visits

In the clinic

Image.

Precision Imaging

More signal than the eye can read, across multiple imaging modalities simultaneously.

In the clinic

Interpret.

Explainable AI

Specialist-grade interpretation, delivered as a calibrated decision the clinician can trust.

Between visits

Follow.

A Skin Diary

Patients capture lesions between visits. DeepDerm flags change to the clinic.

What people are saying

I strongly endorse this initiative. Our unit is committed to supporting it through dermatology expertise and clinical oversight, to advance safe, equitable, and effective skin cancer detection across our region.

A/Prof Chris McCormack

Head, Melanoma & Skin Cancer Unit, Peter MacCallum Cancer Centre

Current treatments still seem like black magic. DeepDerm can provide decision support to doctors and a sense of security to patients.

Klaus

Melanoma patient

The technology works like a normal camera. It is non-invasive, label-free and works in real time, with the potential to reduce biopsies of non-malignant lesions for every patient, regardless of skin tone.

David Malone

CEO, Skin Health Institute

Noor conceived and initiated this work on early melanoma detection, and her enthusiasm has inspired clinicians and researchers from the Skin Health Institute and Peter MacCallum Cancer Centre to get involved. She is a self-starter, always proactive in seeking out new opportunities.

Dr Robin Hill

Electrical & Electronic Engineering, University of Melbourne